Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Genocea Biosciences (GNCA)

0.9363 0.001 (0.14%)

05-24 16:00

Open:

0.925

Pre. Close:

0.935

High:

0.94

Low:

0.9101

Volume:

287,201

Market Cap:

81M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.941 - 0.945

0.945 - 0.949

Low:

0.899 - 0.904

0.904 - 0.909

Close:

0.932 - 0.94

0.94 - 0.947

Technical analysis  (as of: 2018-05-24 5:28:22 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.20     One year: 1.41

Support:

Support1: 0.88    Support2: 0.79

Resistance:

Resistance1: 1.03    Resistance2: 1.20

Pivot:

0.95

Moving Averages:

MA(5): 0.95     MA(20): 0.95

MA(100):     MA(250): 2.45

MACD:

MACD(12,26):     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 47.36     %D(3): 47.55

RSI:

RSI(14): 48.34

52-Week:

High: 6.78  Low: 0.79  Change(%): -84.1

Average Vol(K):

3-Month: 94267  10-Days 57522

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GNCA has closed above bottom band by 39.1%. Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNCA's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-10T14:19:04-04:00
Genocea Biosciences' (GNCA) CEO Chip Clark on Q1 2018 Results - Earnings Call Transcript

2018-05-04T08:00:00-04:00
3 Things In Biotech, May 3: Bristol Bows Out Of IDO, And Two Biotechs Look To Investigate Novel Immunotherapies

2018-03-08T09:20:10-05:00
Premarket Gainers as of 9:05 am (03/08/2018)

2018-03-07T08:00:00-05:00
Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study

2018-03-06T12:45:05-05:00
Midday Gainers / Losers (3/6/2018)

2018-03-06T09:11:52-05:00
Premarket Gainers as of 9:05 am (03/06/2018)

2018-03-05T19:28:26-05:00
Genocea jumps 17.5% as Cantor sees five-bagger potential

2018-02-15T13:28:03-05:00
Genocea Biosciences' (GNCA) CEO Chip Clark on Q4 2017 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

83.06

Shares Float (M)

82.89

% Held by Insiders

0.20

% Held by Institutions

57.70

Shares Short (K)

5783

Shares Short Prior Month (K)

3120

Stock Financials

EPS

-1.640

EPS Est. Current Year

-1.920

EPS Est. Next Year

-1.110

EPS Est. Next Quarter

-0.370

Forward EPS

-0.730

Book Value (p.s.)

20.270

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-129.8

Return on Equity (ttm)

-287.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.489

Qtrly Earnings Growth

Operating Cash Flow (M)

-47.60

Levered Free Cash Flow (M)

-27.37

atoplab.com

Valuation

P/E

-0.57

P/E Growth Ratio

P/BV

0.05

P/S

P/CF

-1.63

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.